{"id":"W4250326583","doi":"10.31525/cmr-1d27113","title":"Simultaneous review decisions for pembrolizumab plus lenvatinib in Australia, Canada and US","year":2019,"lang":"en","type":"article","venue":"Case Medical Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Lenvatinib; Pembrolizumab; Medicine; Internal medicine; Immunotherapy; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002053979,0.0001053696,0.0003683332,0.0001092148,0.00006754821,0.00001215152,0.0001220516,0.0001263837,0.002287121],"category_scores_gemma":[0.009031935,0.00007902785,0.0000530648,0.0003966755,0.0001810276,0.00002322937,0.0000639837,0.0005572068,0.00001795286],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004623712,"about_ca_system_score_gemma":0.003027113,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5622807,"about_ca_topic_score_gemma":0.6748637,"domain_scores_codex":[0.9975178,0.000130556,0.0003582089,0.0003138792,0.001180331,0.0004992487],"domain_scores_gemma":[0.9950041,0.00395878,0.00002704681,0.000324293,0.0002111151,0.0004747081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006653061,0.0001769,0.003200747,0.004522676,0.0001147369,0.04781604,0.0002146132,0.000003530387,0.0005471666,0.00007871522,0.09833833,0.8383335],"study_design_scores_gemma":[0.01220139,0.001032393,0.001903953,0.008169946,0.00003136024,0.009701557,0.0002323275,0.002839043,0.0001376696,0.00006635032,0.9634592,0.0002247997],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9794853,0.01371628,0.000009767488,0.004800241,0.0001299271,0.001460514,0.00003019008,0.000007090344,0.0003606653],"genre_scores_gemma":[0.9816017,0.009875819,0.00006841091,0.002104666,0.00008979658,0.0001010743,0.00002457429,0.00001712953,0.006116895],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8651209,"threshold_uncertainty_score":0.9993154,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1135547015898747,"score_gpt":0.4522904327273504,"score_spread":0.3387357311374757,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}